What is the most recent earnings date for NBIX stock?
NEUROCRINE BIOSCIENCES INC (NBIX) last reported earnings on 2/11/2026.
NEUROCRINE BIOSCIENCES INC (NBIX) Earnings History & Surprises
NASDAQ:NBIX • US64125C1099
Current stock price
127.86 USD
+0.81 (+0.64%)
At close:
127.86 USD
0 (0%)
After Hours:
NBIX Earnings overview
Past quarterly earnings results for NEUROCRINE BIOSCIENCES INC (NBIX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.22
- Revenue Estimate
- 790.13M
Last Reported
Most Recent- Release Date
- Feb 11, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.48
- EPS Surprise
- -22.89%
- Revenue Surprise
- -0.28%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.48 | 1.92 | -22.89% | 48.00% | 805.5M | 807.79M | -0.28% | 28.33% |
| Q3 2025 | 2.04 | 1.62 | 26.10% | 64.52% | 794.9M | 761.45M | 4.39% | 27.78% |
| Q2 2025 | 1.06 | 0.99 | 7.00% | 68.25% | 687.5M | 665.66M | 3.28% | 16.49% |
| Q1 2025 | 0.08 | 0.56 | -85.62% | -80.95% | 572.6M | 573.41M | -0.14% | 11.12% |
| Q4 2024 | 1.00 | 1.59 | -37.18% | -30.56% | 627.7M | 641.57M | -2.16% | 21.84% |
| Q3 2024 | 1.24 | 1.50 | -17.35% | 51.22% | 622.1M | 612.64M | 1.54% | 24.72% |
| Q2 2024 | 0.63 | 1.08 | -41.42% | -33.68% | 590.2M | 556.86M | 5.99% | 30.37% |
| Q1 2024 | 0.42 | 1.03 | -59.17% | 153.16% | 515.3M | 522.21M | -1.32% | 22.57% |
| Q4 2023 | 1.44 | 1.17 | 23.28% | 63.64% | 515.2M | 528.84M | -2.58% | 25.05% |
| Q3 2023 | 0.82 | 0.99 | -16.79% | 18.84% | 498.8M | 479.9M | 3.94% | 28.59% |
| Q2 2023 | 0.95 | 0.79 | 19.84% | 627.78% | 452.7M | 456.25M | -0.78% | 19.70% |
| Q1 2023 | -0.79 | 0.13 | -697.25% | -664.29% | 420.4M | 417.45M | 0.71% | 35.35% |
| Q4 2022 | 0.88 | 1.18 | -25.33% | 1,200.00% | 412M | 417.05M | -1.21% | 32.05% |
| Q3 2022 | 0.69 | 0.81 | -14.90% | 7.81% | 387.9M | 384.51M | 0.88% | 31.05% |
| Q2 2022 | -0.18 | 0.61 | -129.58% | -141.86% | 378.2M | 348.13M | 8.64% | 30.91% |
| Q1 2022 | 0.14 | 0.36 | -60.95% | -57.58% | 310.6M | 310.27M | 0.11% | 31.28% |
| Q4 2021 | -0.08 | 0.53 | -115.18% | -111.11% | 312M | 323.85M | -3.66% | 25.86% |
| Q3 2021 | 0.64 | 0.62 | 3.97% | 203.23% | 296M | 303.75M | -2.55% | 14.51% |
| Q2 2021 | 0.43 | 0.49 | -12.38% | -46.91% | 288.9M | 279M | 3.55% | -4.46% |
| Q1 2021 | 0.33 | 0.52 | -36.84% | -15.38% | 236.6M | 255.65M | -7.45% | -0.21% |
| Q4 2020 | 0.72 | 0.55 | 31.63% | - | 247.9M | 266.32M | -6.92% | - |
| Q3 2020 | -0.62 | 0.17 | -456.57% | - | 258.5M | 288.7M | -10.46% | - |
| Q2 2020 | 0.81 | 0.75 | 8.08% | - | 302.4M | 265.73M | 13.80% | - |
| Q1 2020 | 0.39 | 0.55 | -29.31% | - | 237.1M | 228.35M | 3.83% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-18.85%
Max EPS beat (4)
26.10%
Min EPS beat (4)
-85.62%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
1.81%
Max Revenue beat (4)
4.39%
Min Revenue beat (4)
-0.28%
Analysis
In the last 4 quarters, NBIX has beaten EPS estimates in 2 out of 4 releases
NBIX has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, NBIX reported -18.9% below the EPS estimates on average.
In the last 4 quarters, NBIX has beaten the revenue estimates by 1.8% on average.
Related analysis
NEUROCRINE BIOSCIENCES INC / NBIX Earnings FAQ
Did NBIX stock beat earnings estimates in the most recent quarter?
NEUROCRINE BIOSCIENCES INC (NBIX) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does NBIX stock beat earnings estimates?
In the last 4 quarters, NEUROCRINE BIOSCIENCES INC (NBIX) has beaten EPS estimates in 2 out of 4 releases.